Perbandingan Kadar Malondialdehid pada Penderita Katarak Diabetika dengan Penderita Katarak Non Diabetika
DAFTAR PUSTAKA
American Academy Ophtalmology, Pediatric and Strabismus, Basic and Clinical
Science Course, section 6,Chapter 21, the foundation of the AAO, Sanfransisco
2010-2011,page 245-260.
American Academy Ophtalmology, Lens and Cataract. Basic and clinical Science
Course, Section 11, Sanfransisco 2009 – 2010,page 5-9,34-38,199-204.
Ali N. Al-Oramy, et al. Co-Morbidity of Age Related Cataract Surgical Patients in
Tertiary
Care
Hospital
in
Saudi
Arabia.
Saudi
Journal
of
Ophthalmology,2007;21:105-108
Arimbi AT faktor-faktor yang berhubungan dengan katarak degeneratif di RSUD
Budhi Asih Tahun 2011. Jakarta Universitas Indonesia. 2012.
Artunay O et al, Role of anti-oxidant system and lipid Peroxidation in the
development of age –related and diabetic cataract. Glo-Kat;4;2009 P 221-225.
Bron A.J et al, The Lens In Diabetes, Eye, 1993, 7, p260-275
Chang Dong et al, Serum Antioxidative Enzymes Levels and Oxidative Stress
Products In Age-Related Cataract Patients, Oxidative Medicine and Cellular
Longevity Vol 2013. P1-7.
Congdon G Nathan, et al, Cataract : Clinical Type,Duane‟s Ophthalmology, Vol !,
Chapter 73, 2006.
Daud Nurul, Kadar malondialdehid pada lensa katarak senilis penderita diabetes
mellitus dan non diabetes mellitus kajian di RSUP Dr. Sardjito yogyakarta,
2000. Avaiable at repository.litbang.kemkes.go.id.
Departemen kesehatan RI, 1,5 % penduduk indonesia mengalami kebutaan.
Avaiable at www.depkes.go.id. Di download 20 april 2016
Universitas Sumatera Utara
Effendi M Ma‟sum, Wibowo C,T, Suplementasi Astaxanthin menurunkan kadar
malondialdehid lensa penderita katarak senilis, jurnal kedokteran brawijaya,Vol
27 No 3, 2013.
Fatimah, RN, 2015, Diabetes melitus tipe 2, Jmajority, Vol 4 No 5, P93-101.
France S Stein F & Dawcyzynsky,J, Advance Glycation End product in Anterior
chamber Aquous of cataractous patient, Journal Cataract Refraction
Surgery,2003 29: 329-335.
Javadi M & Ghanavati S, cataract in diabetic patient, A review Article, 2008, journal
of ophthalmic and vission research, 3 52-65.
Jetawattana S, Malondialdehyde (MDA), a lipid oxidation product, Free Radical in
Biology and medicine,77,222,2005.
Johnkennedy N et al, Alterations of serum electrolytes and malondialdehyde in
cataract patients attending general hospital Owerri, Journal of Krishna Of
Medical Sciences University, Vol 4, No 3, 2015.
Joshi N,Caputo GM,Wietekamp MR, Karchnier AW, 1999, Infection in patient with
Diabetes mellitus, J Med Vol 16 p1906-1912.
Goud Manjunatha et al, 2011, Oxidative stress and calcium levels in senile and type
2 Diabetic Cataract patients.
Heydari,B, Kazemi,T, Zarban,A, Ghahraman S, Correlation Of Cataract with serum
lipid, glucose and antioxidant activities A case-control study, West Indian Med
J, 2012, 61,3,p230.
Kanski JJ, 2007-2008. Clinical Ophthalmology A Systematic Approach.Seventh
Edition UK
Karatas F,et al, Determination of Free malondialdehyde in human serum by high
performance liquid chromatography, Analytical Biochemistry,311, 2002, 76-79.
Universitas Sumatera Utara
Katta V Ashok, Katkam RV, Geeta H, Lipid peroxidationand The Total Antioxidant
Status In The patogenesis Of Age Related And Diabetic Cataract : A study on
the Lens And Blood, Journal Of Clinical and Diagnostic Reaserch 2013, Vol 7,
p978-981
Kaur Sumeet, Singh Pal Satinder, Gulraj Uma, Role of malondialdehyde (MDA) in
senile Cataract, The journal of medical Research, 2016, p44-46.
Keputusan Mentri Kesehatan Republik Indonesia Nomor.1473/MENKES/SK/X/2005,
tentang Rencana Strategi Nasional Penanggulangan Gangguan Penglihatan
Dan Kebutaan Untuk Mencapai Vision 2020,p 2-6.
Khurana A.K, Comprehensive Ophthalmology, 4th ed, India : New age Internasional
(P) Ltd Publishings, 2007, page 170-186.
Langston DP, The crystalline lens and cataract in manual of ocular diagnosis and
therapy. Fifth edition,lippincott william & Wilkins. Philadelphia, 2002, P 142.
Marjani A. 2010. Lipid peroxidation alterations in type 2 diabetic patients, Pakistan
Journal of biological science.13(!%): 723-30.
Miranda, M et al, Bioactive Food As Dietary Interventions For Diabetes, 2003, P
275-289.
Moemen A Leqaa et al, 2014, the relationship between advance Glycation End
products and cataractogenesis in diabetics, World Journal Of medical Science
10, 4, p368-374.
Medscape
Reference,
Senile
Catarac,
Drug,
Diseases
http://medicine.medscape.com/article/1210914.Sep 24,2012
&
Procedur
di download
tanggal 15 april 2016
Universitas Sumatera Utara
Nielsen, F., Mikkelsen, B.B., Nielsen, J.B., Andersen, H.R., dan Grandjean, P. 1997.
Plasma Malondialdehyde as Biomarker for Oxidative Stress: Reference Interval
and Effect of Life-style Factors. Journal Clinical Chemistry, 43(7): 1209-1214.
Oliver J, Cassidy L 2005, Ophthalmology at a glance.
Perkumpulan Endokrinologi Indonesia. 2011. Konsensus Pengelolaan Diabetes
Melitus di Indonesia, PB . PERKENI. Jakarta.
Pollreisz A 7 Erfurth U Diabetic Cataract-Patogenesis, Epidemiology and Treatment,
Journal Of Ophthalmology VOL 2010, P1-10.
Pradhevi Lukita, Moegiono, Atika, Effect Of Type Diabetes Mellitus on Cataract
Incidence rate at ophthalmology outpatient clinic DR Soetomo Hospital
Surabaya, Folia Medica Indonesiana Vol 48, No 3, 2012.
Rizkawati, 2012, naskah publikasi, hubungan antara kejadian katarak dengan
diabetes melitus dipoli mata RSUD DR.Soedarso Pontianak.
Sabanayagam et al, Metabolic Syndrome components and age related cataract:the
Singapore Malay Eye Study, Investigative Ophthalmology & Visual Science Vol
52, No 5, 2011.
Setiawan B & Suhartono E, stress oksidatif dan peran antioksidan pada diabetes
melitus, majalah kedokteran indon, 55 ;2 ;2005.
Silalahi E, Prevalensi Kebutaan Akibat Katarak di Kabupaten Karo Tahun 2004,
Bagian Ilmu Penyakit Mata FK USU, Medan, 2004, hal 3, 37-41
Soekardi, Istiantoro & Hutahuruk, Johan A. Transisi Menuju Facoemulsifikasi, 2004.
Singh Zorawar, et al, Use of Malondialdehyde as a biomarker for assessing
oxidative stress in different disease pathologies : a review, Iranian Journal Of
Public health, 2014, 43, p7-16.
Universitas Sumatera Utara
Sirlan Farida, Faktor resiko buta katarak usia produktif: tinjauan khusus terhadap
enzim glutation reduktase dan riboflavin darah, Jakarta, 2000.
Sulistya TB et al, Hubungan antara kadar enzim Glutation Reduktase dengan
derajat kekeruhan inti lensa. majalah kedokteran Indon 55, 2, 2005.
Tana L,Rifati L,Kristanto AY, determinan kejaian katarak di Indonesia, Riset
kesehatan dasar 2007, Buletin penelitian kesehatan, 2009, 37;114-25.
Timothy L.Jackson, Moorfields Manual of Ophthalmology, Chapter 6, Catarac
Surgery, 2008 ; 222-223
VV Agte, KV Tarwadi, Combination of diabetes and cataract worsens the oxidative
stress and micronutrient, J Nutrition, 2008, 617-624.
Zatalia RTS,Sanusi H, The role of antioxidants in the pathophysiology, complications
and management of diabetes melitus, Acta Medica Indonesiana, Vol 45, No 2,
2013, P141-147.
Universitas Sumatera Utara
American Academy Ophtalmology, Pediatric and Strabismus, Basic and Clinical
Science Course, section 6,Chapter 21, the foundation of the AAO, Sanfransisco
2010-2011,page 245-260.
American Academy Ophtalmology, Lens and Cataract. Basic and clinical Science
Course, Section 11, Sanfransisco 2009 – 2010,page 5-9,34-38,199-204.
Ali N. Al-Oramy, et al. Co-Morbidity of Age Related Cataract Surgical Patients in
Tertiary
Care
Hospital
in
Saudi
Arabia.
Saudi
Journal
of
Ophthalmology,2007;21:105-108
Arimbi AT faktor-faktor yang berhubungan dengan katarak degeneratif di RSUD
Budhi Asih Tahun 2011. Jakarta Universitas Indonesia. 2012.
Artunay O et al, Role of anti-oxidant system and lipid Peroxidation in the
development of age –related and diabetic cataract. Glo-Kat;4;2009 P 221-225.
Bron A.J et al, The Lens In Diabetes, Eye, 1993, 7, p260-275
Chang Dong et al, Serum Antioxidative Enzymes Levels and Oxidative Stress
Products In Age-Related Cataract Patients, Oxidative Medicine and Cellular
Longevity Vol 2013. P1-7.
Congdon G Nathan, et al, Cataract : Clinical Type,Duane‟s Ophthalmology, Vol !,
Chapter 73, 2006.
Daud Nurul, Kadar malondialdehid pada lensa katarak senilis penderita diabetes
mellitus dan non diabetes mellitus kajian di RSUP Dr. Sardjito yogyakarta,
2000. Avaiable at repository.litbang.kemkes.go.id.
Departemen kesehatan RI, 1,5 % penduduk indonesia mengalami kebutaan.
Avaiable at www.depkes.go.id. Di download 20 april 2016
Universitas Sumatera Utara
Effendi M Ma‟sum, Wibowo C,T, Suplementasi Astaxanthin menurunkan kadar
malondialdehid lensa penderita katarak senilis, jurnal kedokteran brawijaya,Vol
27 No 3, 2013.
Fatimah, RN, 2015, Diabetes melitus tipe 2, Jmajority, Vol 4 No 5, P93-101.
France S Stein F & Dawcyzynsky,J, Advance Glycation End product in Anterior
chamber Aquous of cataractous patient, Journal Cataract Refraction
Surgery,2003 29: 329-335.
Javadi M & Ghanavati S, cataract in diabetic patient, A review Article, 2008, journal
of ophthalmic and vission research, 3 52-65.
Jetawattana S, Malondialdehyde (MDA), a lipid oxidation product, Free Radical in
Biology and medicine,77,222,2005.
Johnkennedy N et al, Alterations of serum electrolytes and malondialdehyde in
cataract patients attending general hospital Owerri, Journal of Krishna Of
Medical Sciences University, Vol 4, No 3, 2015.
Joshi N,Caputo GM,Wietekamp MR, Karchnier AW, 1999, Infection in patient with
Diabetes mellitus, J Med Vol 16 p1906-1912.
Goud Manjunatha et al, 2011, Oxidative stress and calcium levels in senile and type
2 Diabetic Cataract patients.
Heydari,B, Kazemi,T, Zarban,A, Ghahraman S, Correlation Of Cataract with serum
lipid, glucose and antioxidant activities A case-control study, West Indian Med
J, 2012, 61,3,p230.
Kanski JJ, 2007-2008. Clinical Ophthalmology A Systematic Approach.Seventh
Edition UK
Karatas F,et al, Determination of Free malondialdehyde in human serum by high
performance liquid chromatography, Analytical Biochemistry,311, 2002, 76-79.
Universitas Sumatera Utara
Katta V Ashok, Katkam RV, Geeta H, Lipid peroxidationand The Total Antioxidant
Status In The patogenesis Of Age Related And Diabetic Cataract : A study on
the Lens And Blood, Journal Of Clinical and Diagnostic Reaserch 2013, Vol 7,
p978-981
Kaur Sumeet, Singh Pal Satinder, Gulraj Uma, Role of malondialdehyde (MDA) in
senile Cataract, The journal of medical Research, 2016, p44-46.
Keputusan Mentri Kesehatan Republik Indonesia Nomor.1473/MENKES/SK/X/2005,
tentang Rencana Strategi Nasional Penanggulangan Gangguan Penglihatan
Dan Kebutaan Untuk Mencapai Vision 2020,p 2-6.
Khurana A.K, Comprehensive Ophthalmology, 4th ed, India : New age Internasional
(P) Ltd Publishings, 2007, page 170-186.
Langston DP, The crystalline lens and cataract in manual of ocular diagnosis and
therapy. Fifth edition,lippincott william & Wilkins. Philadelphia, 2002, P 142.
Marjani A. 2010. Lipid peroxidation alterations in type 2 diabetic patients, Pakistan
Journal of biological science.13(!%): 723-30.
Miranda, M et al, Bioactive Food As Dietary Interventions For Diabetes, 2003, P
275-289.
Moemen A Leqaa et al, 2014, the relationship between advance Glycation End
products and cataractogenesis in diabetics, World Journal Of medical Science
10, 4, p368-374.
Medscape
Reference,
Senile
Catarac,
Drug,
Diseases
http://medicine.medscape.com/article/1210914.Sep 24,2012
&
Procedur
di download
tanggal 15 april 2016
Universitas Sumatera Utara
Nielsen, F., Mikkelsen, B.B., Nielsen, J.B., Andersen, H.R., dan Grandjean, P. 1997.
Plasma Malondialdehyde as Biomarker for Oxidative Stress: Reference Interval
and Effect of Life-style Factors. Journal Clinical Chemistry, 43(7): 1209-1214.
Oliver J, Cassidy L 2005, Ophthalmology at a glance.
Perkumpulan Endokrinologi Indonesia. 2011. Konsensus Pengelolaan Diabetes
Melitus di Indonesia, PB . PERKENI. Jakarta.
Pollreisz A 7 Erfurth U Diabetic Cataract-Patogenesis, Epidemiology and Treatment,
Journal Of Ophthalmology VOL 2010, P1-10.
Pradhevi Lukita, Moegiono, Atika, Effect Of Type Diabetes Mellitus on Cataract
Incidence rate at ophthalmology outpatient clinic DR Soetomo Hospital
Surabaya, Folia Medica Indonesiana Vol 48, No 3, 2012.
Rizkawati, 2012, naskah publikasi, hubungan antara kejadian katarak dengan
diabetes melitus dipoli mata RSUD DR.Soedarso Pontianak.
Sabanayagam et al, Metabolic Syndrome components and age related cataract:the
Singapore Malay Eye Study, Investigative Ophthalmology & Visual Science Vol
52, No 5, 2011.
Setiawan B & Suhartono E, stress oksidatif dan peran antioksidan pada diabetes
melitus, majalah kedokteran indon, 55 ;2 ;2005.
Silalahi E, Prevalensi Kebutaan Akibat Katarak di Kabupaten Karo Tahun 2004,
Bagian Ilmu Penyakit Mata FK USU, Medan, 2004, hal 3, 37-41
Soekardi, Istiantoro & Hutahuruk, Johan A. Transisi Menuju Facoemulsifikasi, 2004.
Singh Zorawar, et al, Use of Malondialdehyde as a biomarker for assessing
oxidative stress in different disease pathologies : a review, Iranian Journal Of
Public health, 2014, 43, p7-16.
Universitas Sumatera Utara
Sirlan Farida, Faktor resiko buta katarak usia produktif: tinjauan khusus terhadap
enzim glutation reduktase dan riboflavin darah, Jakarta, 2000.
Sulistya TB et al, Hubungan antara kadar enzim Glutation Reduktase dengan
derajat kekeruhan inti lensa. majalah kedokteran Indon 55, 2, 2005.
Tana L,Rifati L,Kristanto AY, determinan kejaian katarak di Indonesia, Riset
kesehatan dasar 2007, Buletin penelitian kesehatan, 2009, 37;114-25.
Timothy L.Jackson, Moorfields Manual of Ophthalmology, Chapter 6, Catarac
Surgery, 2008 ; 222-223
VV Agte, KV Tarwadi, Combination of diabetes and cataract worsens the oxidative
stress and micronutrient, J Nutrition, 2008, 617-624.
Zatalia RTS,Sanusi H, The role of antioxidants in the pathophysiology, complications
and management of diabetes melitus, Acta Medica Indonesiana, Vol 45, No 2,
2013, P141-147.
Universitas Sumatera Utara